How men with non-chlamydial, non-gonococcal urethritis are managed in Australasia

Abstract

The aim of this study was to ascertain how sexual health physicians in Australia and New Zealand manage men with chlamydia-negative non-gonococcal urethritis (NGU), particularly in relation to the notification of their female sexual partners. In July 2006, a cross-section survey was sent out to all the members of the Australasian Chapter of Sexual Health Medicine. Seventy-three percent of sexual health physicians believed that female partners of men who present with chlamydia-negative NGU were at risk of adverse reproductive health outcomes. At least 62% usually initiated some form of partner notification of female partners of men with chlamydia-negative NGU. However, only 19% (21/111) of sexual health physicians routinely tested for, and only 65% sometimes tested for, pathogens other than Neisseria gonorrhoeae and Chlamydia trachomatis in men presenting with NGU. These included Mycoplasma genitalium, herpes simplex virus, ureaplasma species, Trichomonas vaginalis and adenoviruses.

Mycoplasma genitalium in men who have sex with men at male-only saunas

“…It has undergone accreditation by our National Laboratory Accreditation Authority (NATA), and has been employed in a number of our previously published studies. [12][13][14][15][16] The human b-globin gene was amplified by realtime PCR from all samples to act as an internal control to evaluate sample adequacy, inhibition and integrity following storage. 17 Samples negative for both b-globin and M genitalium were deemed not assessable.…”